Kuraray
Kuraray (Japan) holds 0 active US FDA Type II Drug Master Files and 4 inactive. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Kuraray: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/kuraray
Overview
Kuraray is a chemical manufacturer headquartered in Otemachi, Japan.
API / Drug Master Files
Kuraray holds 0 active (4 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- (1S,3R,20S)-20-(3-HYDROXY-3-METHYLBUTLOXY) PREGNA-5,7-DIENE-1,3-DIOLInactive1997-02-05
- 1S,3S,4R-3-(2-PROPENYL)-BICYCLO[2,2,1] HEPTAN-2-ONEInactive1993-03-01
- (-) -HPBEInactive1990-06-18
- FACILITIES AND OPERATING PROCEDURES IN NIIGATA, JAPAN.Inactive1990-06-18
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Kuraray in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Kuraray?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.